Cormorant Asset Management, LP - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 88 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$732
-100.0%
150,0000.0%0.05%
-67.5%
Q3 2022$2,163,000
-4.7%
150,0000.0%0.15%
-12.2%
Q2 2022$2,270,000
+27.4%
150,0000.0%0.17%
+25.5%
Q1 2022$1,782,000
-63.4%
150,000
-50.0%
0.14%
-52.6%
Q4 2021$4,863,000
-65.9%
300,000
-40.0%
0.29%
-50.2%
Q3 2021$14,270,000
-47.2%
500,000
-37.5%
0.58%
-36.9%
Q2 2021$27,040,000
-27.3%
800,000
-35.0%
0.92%
+10.9%
Q1 2021$37,195,000
-54.8%
1,230,000
-26.0%
0.83%
-57.7%
Q4 2020$82,268,000
+53.3%
1,661,647
+18.9%
1.96%
-5.1%
Q3 2020$53,658,000
-21.1%
1,397,700
-11.2%
2.06%
-20.5%
Q2 2020$68,026,000
+50.5%
1,574,683
-9.1%
2.60%
+23.6%
Q1 2020$45,210,000
-9.7%
1,732,200
+8.1%
2.10%
+5.2%
Q4 2019$50,074,000
+117.4%
1,602,376
+81.3%
2.00%
+42.5%
Q3 2019$23,032,000
+0.7%
883,800
-11.6%
1.40%
+6.7%
Q2 2019$22,870,000
+22.0%
1,000,000
+39.8%
1.31%
+3.7%
Q1 2019$18,753,000
+373.4%
715,482
+267.4%
1.27%
+293.5%
Q4 2018$3,961,000
-25.4%
194,768
-2.6%
0.32%
-6.7%
Q3 2018$5,312,000200,0000.34%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 2,194,278$108,639,0006.47%
Memorial Sloan Kettering Cancer Center 216,916$10,740,0004.55%
Burrage Capital Management LLC 114,962$5,692,0004.34%
MPM BioImpact LLC 674,582$33,398,0002.88%
First Light Asset Management, LLC 635,652$31,471,0002.33%
Cormorant Asset Management, LP 1,661,647$82,268,0001.96%
ASHFORD CAPITAL MANAGEMENT INC 219,419$10,863,0001.05%
ORACLE INVESTMENT MANAGEMENT INC 126,342$6,255,0000.78%
SPHERA FUNDS MANAGEMENT LTD. 131,016$6,487,0000.58%
Artal Group S.A. 285,028$14,112,0000.30%
View complete list of Y-MABS THERAPEUTICS INC shareholders